Mast cells as regulators of T cell responses

Frontiers in Immunology

Volumn 6, Issue AUG, 2015, Pages

  Bulfone Paus, Silvia ^a   Bahri, Rajia ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adaptive immunity; CD4 T cell; CD8 T cell; Mast cells; Treg cells

Indexed keywords

B7 ANTIGEN; CD137 LIGAND; CD30 LIGAND; CD86 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEUROPEPTIDE RECEPTOR; OX40 LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROTEINASE; RANTES; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HOMEOSTASIS; HUMAN; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84941277572     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00394     Document Type: Short Survey

References (59)

1. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol (2008) 8:478-86. doi:10.1038/nri2327.
2. Gurish MF, Austen KF. Developmental origin and functional specialization of mast cell subsets. Immunity (2012) 37:25-33. doi:10.1016/j.immuni.2012.07.003.
3. Sugawara K, Bíró T, Tsuruta D, Tóth BI, Kromminga A, Zákány N, et al. Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol (2012) 129:726-38. doi:10.1016/j.jaci.2011.11.009.
4. Janssens AS, Heide R, den Hollander JC, Mulder PG, Tank B, Oranje AP. Mast cell distribution in normal adult skin. J Clin Pathol (2005) 58:285-9. doi:10.1136/jcp.2004.017210.
5. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol (2010) 10:440-52. doi:10.1038/nri2782.
6. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med (2012) 18:693-704. doi:10.1038/nm.2755.
7. Walker ME, Hatfield JK, Brown MA. New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim Biophys Acta (2012) 1822:57-65. doi:10.1016/j.bbadis.2011.02.009.
8. Rodewald HR, Feyerabend TB. Widespread immunological functions of mast cells: fact or fiction? Immunity (2012) 37:13-24. doi:10.1016/j.immuni.2012.07.007.
9. Jobbings CE, Sandig H, Whittingham-Dowd JK, Roberts IS, Bulfone-Paus S. Listeria monocytogenes alters mast cell phenotype, mediator and osteopontin secretion in a listeriolysin-dependent manner. PLoS One (2013) 8:e57102. doi:10.1371/journal.pone.0057102.
10. McLachlan JB, Shelburne CP, Hart JP, Pizzo SV, Goyal R, Brooking-Dixon R, et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med (2008) 14:536-41. doi:10.1038/nm1757.
11. Valitutti S, Espinosa E. Cognate interactions between mast cells and helper T lymphocytes. Self Nonself (2010) 1:114-22. doi:10.4161/self.1.2.11795.
12. Gri G, Frossi B, D'Inca F, Danelli L, Betto E, Mion F, et al. Mast cell: an emerging partner in immune interaction. Front Immunol (2012) 3:120. doi:10.3389/fimmu.2012.00120.
13. Mekori YA, Hershko AY, Frossi B, Mion F, Pucillo CE. Integrating innate and adaptive immune cells: mast cells as crossroads between regulatory and effector B and T cells. Eur J Pharmacol (2015). doi:10.1016/j.ejphar.2015.03.087.
14. Kambayashi T, Laufer TM. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol (2014) 14:719-30. doi:10.1038/nri3754.
15. Frandji P, Oskéritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol (1993) 151:6318-28.
16. Fox CC, Jewell SD, Whitacre CC. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol (1994) 158:253-64. doi:10.1006/cimm.1994.1272.
17. + T cell hybridomas by human mast cells through superantigen presentation. J Leukoc Biol (1999) 66:105-12.
18. + T cells through antigen-dependent interactions. Eur J Immunol (2013) 43:1758-68. doi:10.1002/eji.201243058.
19. Frandji P, Tkaczyk C, Oskéritzian C, Lapeyre J, Peronet R, David B, et al. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol (1995) 163:37-46. doi:10.1006/cimm.1995.1096.
20. Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mecheri S. Exogenous and endogenous antigens are differentially presented by mast cells to CD4 T lymphocytes. Eur J Immunol (1996) 26:2517-28. doi:10.1002/eji.1830261036.
21. Tkaczyk C, Villa I, Peronet R, David B, Mecheri S. FceRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology (1999) 97:333-40. doi:10.1046/j.1365-2567.1999.00789.x.
22. Gaudenzio N, Espagnolle N, Mars LT, Liblau R, Valitutti S, Espinosa E. Cell-cell cooperation at the T helper cell/mast cell immunological synapse. Blood (2009) 114:4979-88. doi:10.1182/blood-2009-02-202648.
23. + T cells toward an inflammatory IL-22+ phenotype. J Allergy Clin Immunol (2013) 131:1400-7. doi:10.1016/j.jaci.2013.01.029.
24. Kambayashi T, Allenspach EJ, Chang JT, Zou T, Shoag JE, Reiner SL, et al. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol (2009) 182:4686-95. doi:10.4049/jimmunol.0803180.
25. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol (2006) 176:2238-48. doi:10.4049/jimmunol.176.4.2238.
26. Nakano N, Nishiyama C, Yagita H, Koyanagi A, Akiba H, Chiba S, et al. Notch signaling confers antigen-presenting cell functions on mast cells. J Allergy Clin Immunol (2009) 123:74-81. doi:10.1016/j.jaci.2008.10.040.
27. Fujita T, Kambe N, Uchiyama T, Hori T. Type I interferons attenuate T cell activating functions of human mast cells by decreasing TNF-alpha production and OX40 ligand expression while increasing IL-10 production. J Clin Immunol (2006) 26:512-8. doi:10.1007/s10875-006-9043-1.
28. Gong J, Yang NS, Croft M, Weng IC, Sun L, Liu FT, et al. The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FceRI and MHC II. BMC Immunol (2010) 11:34. doi:10.1186/1471-2172-11-34.
29. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell (1997) 8:2631-45. doi:10.1091/mbc.8.12.2631.
30. Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol (2001) 166:868-76. doi:10.4049/jimmunol.166.2.868.
31. + T cells by a mechanism dependent on CCR5 ligands. FASEB J (2012) 26:1280-9. doi:10.1096/fj.11-188979.
32. Avirutnan P, Matangkasombut P. Unmasking the role of mast cells in dengue. Elife (2013) 30(2):e00767. doi:10.7554/eLife.00767.
33. Liu B, Meng D, Wei T, Zhang S, Hu Y, Wang M. Apoptosis and pro-inflammatory cytokine response of mast cells induced by influenza A viruses. PLoS One (2014) 9(6):e100109. doi:10.1371/journal.pone.0100109.
34. Ebert S, Becker M, Lemmermann NA, Büttner JK, Michel A, Taube C, et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog (2014) 10(4):e1004100. doi:10.1371/journal.ppat.1004100.
35. Al-Afif A, Alyazidi R, Oldford SA, Huang YY, King CA, Haidl ID, et al. Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4. J Allergy Clin Immunol (2015). doi:10.1016/j.jaci.2015.01.042.
36. Sandig H, Bulfone-Paus S. TLR signaling in mast cells: common and unique features. Front Immunol (2012) 3:185. doi:10.3389/fimmu.2012.00185.
37. + T-cell recruitment. Blood (2005) 106:978-87. doi:10.1182/blood-2004-07-2656.
38. Becker M, Lemmermann NA, Ebert S, Baars P, Renzaho A, Podlech J, et al. Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and-independent mechanisms. Cell Mol Immunol (2015) 12:192-201. doi:10.1038/cmi.2014.73.
39. + T cells through production of leukotriene B4. Nat Immunol (2003) 4:974-81. doi:10.1038/ni971.
40. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol (1996) 156:1490-6.
41. + T-cells may contribute to the pathogenesis of alopecia areata. PLoS One (2014) 9(5):e94260. doi:10.1371/journal.pone.0094260.
42. + T cell effector functions. Immunity (2009) 31:665-76. doi:10.1016/j.immuni.2009.08.022.
43. Gregory GD, Robbie-Ryan M, Secor VH, Sabatino JJ Jr, Brown MA. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur J Immunol (2005) 35:3478-86. doi:10.1002/eji.200535271.
44. Maurer M, Lopez Kostka S, Siebenhaar F, Moelle K, Metz M, Knop J, et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J (2006) 20:2460-7. doi:10.1096/fj.06-5860com.
45. + regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol (2005) 174:7141-6. doi:10.4049/jimmunol.174.11.7141.
46. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature (2006) 442:997-1002. doi:10.1038/nature05010.
47. Eller K, Wolf D, Huber JM, Metz M, Mayer G, McKenzie AN, et al. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol (2011) 186:83-91. doi:10.4049/jimmunol.1001183.
48. Kashyap M, Thornton AM, Norton SK, Barnstein B, Macey M, Brenzovich J, et al. Cutting edge: CD4 T cell-mast cell interactions alter IgE receptor expression and signaling. J Immunol (2008) 180:2039-43. doi:10.4049/jimmunol.180.4.2039.
49. Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood (2009) 114:2639-48. doi:10.1182/blood-2009-05-220004.
50. + T regulatory cell suppressor function via histamine H1 receptor interaction. J Immunol (2009) 183:3014-22. doi:10.4049/jimmunol.0802509.
51. + regulatory T cell interactions. Eur J Immunol (2011) 41:1872-82. doi:10.1002/eji.201041300.
52. + regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity (2008) 29:771-81. doi:10.1016/j.immuni.2008.08.018.
53. Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M, et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity. Immunity (2011) 35:832-44. doi:10.1016/j.immuni.2011.09.015.
54. Gutierrez DA, Fu W, Schonefeldt S, Feyerabend TB, Ortiz-Lopez A, Lampi Y, et al. Type 1 diabetes in NOD mice unaffected by mast cell deficiency. Diabetes (2014) 63:3827-34. doi:10.2337/db14-0372.
55. Lilla JN, Chen CC, Mukai K, BenBarak MJ, Franco CB, KalesnikoffJ, et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/flmice. Blood (2011) 118:6930-8. doi:10.1182/blood-2011-03-343962.
56. Reber LL, Marichal T, Galli SJ. New models for analyzing mast cell functions in vivo. Trends Immunol (2012) 33:613-25. doi:10.1016/j.it.2012.09.008.
57. Schubert N, Dudeck J, Liu P, Karutz A, Speier S, Maurer M, et al. Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed. Arthritis Rheumatol (2015) 67:903-13. doi:10.1002/art.38996.
58. Brown MA, Hatfield JK, Walker ME, Sayed BA. A game of kit and mouse: the Kit is still in the bag. Immunity (2012) 36:891-2; author reply 893-894. doi:10.1016/j.immuni.2012.05.004.
59. Brown MA, Hatfield JK. Mast cells are important modifiers of autoimmune disease: with so much evidence, why is there still controversy? Front Immunol (2012) 3:147. doi:10.3389/fimmu.2012.00147.